Unexpectedly Rapid Onset of Severe Sarcopenia in an Elderly Diabetic Man following SGLT2i Administration: A Case Report
Open Access
- 11 May 2024
- journal article
- case report
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (10) , 2828
Abstract
Sarcopenia is characterized by the progressive loss of muscle mass, strength, and function and poses a significant health challenge among people with diabetes. Sodium–glucose cotransporter-2 inhibitors (SGLT2is) are the backbone of type 2 diabetes treatment. The interplay between SGLT2is and sarcopenia is an area of active research with inconclusive results. This article presents an unexpectedly rapid weight reduction, along with physical performance deterioration, in an elderly patient with type 2 diabetes, which led to treatment discontinuation. A bioelectrical impedance analysis confirmed severe sarcopenia development. Until more data are available, sarcopenia and body composition screening and monitoring may be warranted whenever SGLT2is are prescribed.Keywords
This publication has 32 references indexed in Scilit:
- The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative ReviewDiabetes Therapy, 2023
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2022
- Body composition assessment using bioelectrical impedance analysis (BIA) in a wide cohort of patients affected with mild to severe obesityClinical Nutrition, 2021
- Emerging Role of SGLT-2 Inhibitors for the Treatment of ObesityDrugs, 2019
- The actions of SGLT2 inhibitors on metabolism, renal function and blood pressureDiabetologia, 2018
- Validation of the SarQoL®, a specific health‐related quality of life questionnaire for SarcopeniaJournal of Cachexia, Sarcopenia and Muscle, 2016
- Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older menAge and Ageing, 2016
- Application of standards and models in body composition analysisProceedings of the Nutrition Society, 2015
- Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and olderOsteoporosis International, 2015
- Changes in fat-free mass during significant weight loss: a systematic reviewInternational Journal of Obesity, 2006